Akihiko Shimauchi
Direktor/Vorstandsmitglied bei CHORDIA THERAPEUTICS INC.
Profil
Akihiko Shimauchi is the founder of INDEE Medical, Inc. He is currently an Independent Outside Director at Chordia Therapeutics, Inc. since 2018.
He previously held positions as President & Chief Executive Officer at Fujirebio, Inc., Executive Director, GM-Sales & Marketing at Ortho-Clinical Diagnostics KK, Principal at Ajinomoto Co., Inc., Principal at American Hospital Supply Corp., President-Product Development Services Division at Quintiles Transnational Japan K.K., and President at M's Science Corp.Mr. Shimauchi obtained his undergraduate degree from Waseda University.
Aktive Positionen von Akihiko Shimauchi
| Unternehmen | Position | Beginn |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.10.2022 |
INDEE Medical, Inc.
 INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Gründer | - |
Ehemalige bekannte Positionen von Akihiko Shimauchi
| Unternehmen | Position | Ende |
|---|---|---|
| Ortho-Clinical Diagnostics KK | Direktor/Vorstandsmitglied | - |
Fujirebio, Inc.
 Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Präsident | - |
| American Hospital Supply Corp. | Corporate Officer/Principal | - |
| AJINOMOTO CO., INC. | Corporate Officer/Principal | - |
Quintiles Transnational Japan K.K.
 Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Corporate Officer/Principal | - |
Ausbildung von Akihiko Shimauchi
| Waseda University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AJINOMOTO CO., INC. | Consumer Non-Durables |
| Private Unternehmen | 7 |
|---|---|
Fujirebio, Inc.
Fujirebio, Inc. Medical SpecialtiesHealth Technology Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan. | Health Technology |
| American Hospital Supply Corp. | Health Technology |
Quintiles Transnational Japan K.K.
Quintiles Transnational Japan K.K. Pharmaceuticals: MajorHealth Technology Part of Quintiles Transnational Corp., Quintiles Transnational Japan K.K. is a Japanese company that manufactures and distributes pharmaceutical drugs and provides training services for medical professionals. The company is based in Tokyo, Japan. Yoh Narimatsu has been the CEO of the company since 2006. | Health Technology |
| Ortho-Clinical Diagnostics KK | |
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
INDEE Medical, Inc.
INDEE Medical, Inc. Medical SpecialtiesHealth Technology INDEE Medical, Inc. engages in the manufacture and sale of medical related products. It distributes ReCell, a treatment kit that creates cell suspension once sprayed or applied on wounds with damage. It is also being used for scars, vitiligo, nevus, leg ulcers, and in cosmetic surgery. The company was founded in January 2016 and is headquartered in Tokyo, Japan. | Health Technology |
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chordia Therapeutics, Inc. engages in the research and development of novel therapies for cancers. It handles research and development of low-molecular-weight drugs with unprecedented new mechanisms of action in the oncology area. The company was founded by Hiroshi Miyake and Daisuke Morishita on October 12, 2017 and is headquartered in Fujisawa, Japan. | Health Technology |
